Antonino (Bruno) Tuttolomondo

Born in Palermo ( Italy) on July 21 th ,1970

1996 MD, University of Palermo
2001 Post-Graduate Diploma on Internal Medicine
University of Palermo
2003 PhD : Genetic and pathophysiology of cardiovascular damage in endocrin metabolic disease.
2004 Assistant Professor of Internal Medicine , University of Palermo
2010: Post-Graduate, Neurology, University of Palermo
2019: MSCs: Master of Sciences, Stroke Medicine European Master of European Stroke Organization ( ESO)
2015-2019 : Associate Professor of Internal Medicine, University of Palermo ( Italy)
since 2018 Director of Molecular and Clinical Medicine PhD Programme of University of Palermo
2019 : ( actual) Full Professor of Internal Medicine University of Palermo (Italy)
2020: Chief of the Internal Medicine and Stroke Care Ward. University Policlinico “P. GIaccone”; Palermo

Reviewer of the ISI and with impact factor journals : ” “Journal of Diabetic Complications”, “Journal of Internal Medicine”, “Journal of Neurological Sciences”, “Haematologica”, “Plos-one”, ” European Journal of Neurology” “Journal of Pharmacology and Pharmacy”, European Journal of Internal Medicine” “Pediatric Research” “Metabolism”, “Brain Research “, “Cardiovascular Diabetology” , ” Journal of Translational Medicine” “Atherosclerosis” , ” Clinical and Applied Thrombosis and Haemostasis” “Cytokine”, ” Neurology” , “Biomarkers”, ” Journal of Neuroinflammation”, ” International Immunopharmacology”,”American Journal of Hypertension”,”Journal of Cardiovascular Medicine”, ” Neurological Research” “Journal of Neurology, Neurosurgery and Psichiatry”, “BMC Neurology”, “International Journal of Cardiology”, “Diabetology & Metabolic Syndrome” “Journal of Infection and Public Health”, “Future Neurology”,” BMJ Case Reports”, “Molecular Genetics and Metabolism” “Metabolic Brain Disease” “Regenerative Medicine Research””Lipids in Health”, ” Molecular Biology Reports””Journal of American College of Nutrition” “Behavioral and Brain Functions”, ” European Journal of Heart failure” “Annals of Medicine ” International Journal of Medical Science””Expert Opinion on Therapeutic Target” ” Stroke” , Medicine” “Expert Opinion on Investigational Drugs “, “Journal of Pharmaceutical Sciences”,”Clinical and Experimental Medicine”,” “Journal of the American Heart Association (JAHA), “Scandinavian Journal of Immunology”, “Frontiers in Endocrinology-diabetes” e della rivista internazionale” , “Vascular Health and Risk Management”, “International Journal of Nephrology and Renovascular Disease”, “International Journal of Medical Sciences”, “Journal of Neuroimmune Pharmacology”, ” Drug,Design and Development” “Current Pharmaceutical Design”, “Current Genomenics” “Evidence-Based Complementary and Alternative Medicine”, ” Multiple Sclerosis Journal””Brain Research” “Oncotarget” “Molecular Nutrition and Food Research”, “British Journal of Nutrition” “American Heart Journal” “ Gut Pathogens” and Open Diabetes Journal”

Cctual Member of the Editorial Board of the ISI Journals with impact factor: European Journal of Internal Medicine (IF: 4.18) , International Journal of Molecular Sciences ( IF: 4.55), Internal Medicine and Emergency ( IF: 2.23) , Current Pharmaceutical Design ( IF: 230)
Academic Editor of the ISI Journal with IF: Medicine
• Author of more than 300 publications mostly published in international journals, ISI and referees committee and medium-high impact factor and inherent in the pathophysiology and epidemiology of ischemic stroke and in particular the evaluation of the activation of the acute phase of immunoinfiammatoria ‘ acute ischemic stroke , the relationship between cardiovascular risk factors and diagnostic subtypes ( TOAST ) cerebral ischemia , the possible role of predictive variables immunoinfiammatorie in the diagnosis of acute ischemic stroke. Further research interests are related to the role of therapy with high-dose furosemide and small-volume hypertonic saline therapy and refractory heart failure and refractory ascites , the role of the salt load in the acute characterize and stratify patients with congestive heart failure after therapy with high doses of furosemide and small volumes of hypertonic saline , the atherosclerosis as inflammatory disease and characterization of the diabetic foot as risk markers cardiovascolare.Further interests are represented by Anderson-Fabry disease , and in particular of its role as risk factor of cryptogenic stroke over over which the search for new mutations in the gene for alpha- Galactosidase.







Bibliometric indexes
• H-index ( Scopus) : 53
• H index (Google Scholar) : 60
i10-index
( Google Scholar) : 156
• citations ( Scopus): 7225
• total (Google Scholar) 11210


Key words
Ischemic stroke, stroke subtypes, inflammation, cytokines, diabetic foot, congestive heart failure, Fabry Disease